SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-22-005732
Filing Date
2022-05-02
Accepted
2022-05-02 16:03:50
Documents
5

Document Format Files

Seq Description Document Type Size
1 SCHEDULE-14A ndra_defa14a.htm DEFA14A 28953
2 ndra_defa14aimg1.jpg GRAPHIC 1355
3 ndra_defa14aimg2.jpg GRAPHIC 1093
4 ndra_defa14aimg3.jpg GRAPHIC 1064
5 ndra_defa14aimg4.jpg GRAPHIC 1219
  Complete submission text file 0001654954-22-005732.txt   37093
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37969 | Film No.: 22881863
SIC: 3845 Electromedical & Electrotherapeutic Apparatus